Defibrotide activity in experimental frostbite injury

British Journal of Plastic Surgery

Volumn 51, Issue 6, 1998, Pages 450-454

  Ozyazgan I ^a   Tercan, M ^b   Bekerecioglu M ^c   Melli, M ^d   Ustun H ^e   Gunay G K ^a  

^a ERCIYES UNIVERSITY   (Turkey)

^b INONU UNIVERSITY   (Turkey)

^c YUZUNCU YIL UNIVERSITY   (Turkey)

^d ANKARA UNIVERSITY   (Turkey)

^e Ankara State Hospital   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

6 OXOPROSTAGLANDIN F1 ALPHA; DEFIBROTIDE; PROSTACYCLIN; THROMBOXANE A2; THROMBOXANE B2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COLD INJURY; CONTROLLED STUDY; FEMALE; INFLAMMATION; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MAST CELL; NEUTROPHIL; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; RABBIT; REPERFUSION INJURY;

EID: 0032168583     PISSN: 00071226     EISSN: None     Source Type: Journal    
DOI: 10.1054/bjps.1997.0061     Document Type: Article

References (44)

1. 1. Rakower SR, Shahgoli S, Wong SL. Doppler ultrasound and digital plethysmography to determine the need for sympathetic blockade after frostbite. J Trauma 1978; 18: 713-8.
2. 2. Snider RL, Porter JM. Treatment of experimental frostbite with intra-arterial sympathetic blocking drugs. Surgery 1975; 77: 557-61.
3. 3. Bourne MH, Piepkorn MW, Clayton F, Leonard LG. Analysis of microvascular changes in frostbite injury. J Surg Res 1986; 10: 26-35.
4. 4. Reite PB. I Functional qualities of small blood vessels in tissue injured by freezing and thawing. Acta Physiol Scand 1965; 63: 111-20.
5. 5. Weatherly-White RCA, Sjostrom BL, Paton BC. Experimental studies in cold injury. II: The pathogenesis of frostbite. J Surg Res 1964; 4: 17-22.
6. 6. Kulka JP. Cold injury of the skin. The pathogenic role of microcirculatory impairment. Arch Environ Health 1965; 2: 484-97.
7. 7. Ley K, Arfars KL. Changes in macromolecular permeability by intravascular generation of oxygen-derived free radicals. Microvasc Res 1982; 24: 25-33.
8. 8. Marzella L, Jesudas RR, Manson PN, Myers RA, Bulkley GB. Morphologic characterization of acute injury to vascular endothelium of skin after frostbite. Plast Reconstr Surg 1989; 83: 67-76.
9. 9. Mileski WJ, Raymond JF, Winn RK, Harlan JM, Rice CL. Inhibition of leukocyte adherence and aggregation for treatment of severe cold injury in rabbits. J. Appl. Physiol 1993; 74: 1432-6.
10. 10. Schrör K, Ackermann G, Hohlfeld T, et al. Endothelial protection by defibrotide - a new strategy for treatment of myocardial infarction? Z Kardiol 1989; 78: 35-41.
11. 11. Lefer AM, Aoki N, Mulloy D. Coronary endothelium-protective effects of defibrotide in ischemia and reperfusion. Naunyn-Schmiedebergs Arch Pharmacol 1990; 341: 246-50.
12. 12. Aoki N, Siegfried M, Tsao P, Lento P, Lefer AM. Beneficial mechanisms of action of a prostacyclin enhancing agent in splanchnic artery occlusion shock. Res Commun Chem Pathol Pharmacol 1988; 60: 275-89.
13. 13. Hohlfeld T, Bucha E, Nowak G, Brüggener E, Strobach H, Schrör K. Favourable effect of Defibrotide in lipid A-induced shock in pigs. Circ Shock 1992; 38: 122-9.
14. 14. Fumagalli G, Angelaccio E, Lombarde N, Clementi F. Morphometric and ultrastructural study of experimental venous thrombosis. Effects of defibrotide, an antithrombotic agent. Haemostasis 1987; 17: 361-70.
15. 15. Fumagalli G, Sala C, Angelaccio E, Lombardo N, Clementi F. Thrombolytic activity of dofibrotide: a morphometric evaluation in experimental venous thrombosis. Pharmacol Res 1989; 21: 293-8.
16. 16. Hohlfeld T, Strobach H, Schrör K. Stimulation of endogenous prostacyclin protects the reperfused pig myocardium from ischemic injury. J Pharmacol Exp Ther 1993; 264: 397-405.
17. 17. Ma XL, Porta R, Pescador R, Lefer AM. Novel beneficial mechanisms of defibrotide, a prostacyclin enhancing agent in splanchnic artery occlusion and reperfusion in rats. Meth Find Exp Clin Pharmacol 1991; 13: 667-74.
18. 18. Gambassi F, Lupini M, Di Bello MG, Mugnai L, Masini E, Mannaioni PF. Histamine release by free radicals: effect of Defibrotide (DFT) and its fraction 'PO.085 DV'. Agents Actions 1993; 38: Special Conference Issue, C206-C208.
19. 19. Pescador R, Porta R, Ferro L. An integrated view of the activities of Defibrotide. Semin Thromb Hemost 1996; 22: 71-5.
20. 20. Thiemermann C, Löbel P, Schrör K. Usefulness of defibrotide in protecting ischemic myocardium from early reperfusion damage. Am J Cardiol 1985; 56: 978-82.
21. 21. Manson PN, Jesudass R, Marzella L, Bulkley GB, Im MJ, Narayan KK. Evidence for an early free radical-mediated reperfusion injury in frostbite. Free Radic Biol Med 1991; 10: 7-11.
22. 22. Raine I, London MD, Goluch L, et al. Antiprostaglandins and antithromboxanes for treatment of frostbite. Surgical Forum 1980; 31: 557.
23. 23. Knize DM, Weatherley-White RCA, Paton BC. Use of anti-sludging agents in experimental cold injuries. Surg Gynecol Obstet 1969; 129: 1019-26.
24. 24. Sjostrom B, Weatherley-White RCA, Paton C. Experimental studies in cold injury I. The individual response to standard cold environment. J Surg Res 1964; 4: 12.
25. 25. Weatherley-White RCA, Sjostrom B, Paton C. Experimental studies in cold injury II. The pathogenesis of frostbite. J Surg Roc 1964; 4: 17.
26. 26. Powell WS. Rapid extraction of oxygenated metabolites of arachidonic acid from biological samples using octadecylsilyl silica. Prostaglandins 1980; 20: 947-57.
27. 27. Pradelles P, Grassi J, Maclouf J. Enzyme immunoassays of eicosanoids using acetylcholine esterase as label: an alternative to radioimmunoassay. Anal Chem 1985; 57: 1170-3.
28. 28. Finseth F, Adelberg MG. Prevention of skin flap necrosis by a course of treatment with vasodilator drugs. Plast Reconstr Surg 1978; 61: 738-43.
29. 29. Mileski WJ, Raymond JF, Winn RK, Harlan JM, Rice CL. Inhibition of leukocyte adherence and aggregation for treatment of severe cold injury in rabbits. J Appl Physiol 1993; 74: 1432.
30. 30. Reilly PM, Schiller HJ, Bulkley GB. Pharmacologic approach to tissue injury mediated by free radicals and other reactive oxygen metabolites Am J Surg 1991; 161: 488-503.
31. 31. Welbourn CRB, Goldman G, Paterson IS, Valeri CR, Shepro D, Hechtman HB. Pathophysiology of ischaemia reperfusion injury: central role of the neutrophil. Br J Surg 1991; 78: 651-5.
32. 32. Waris T, Kyösola K. Cold injury of the rat skin. A fluorescence histochemical study of adrenergic nerves, mast cells and patency of cutaneous blood vessels. Scand J Plast Reconstr Surg 1982; 16: 1-9.
33. 33. Tettamanti R, Bianchi G, Vitte PA, et al. A novel insight into the mechanism of the antithrombotic action of defibrotide. Life Sci 1992; 51: 1545-55.
34. 34. Rajagopalan S, McIntire LV, Hall ER, Wu KK. The stimulation of arachidonic acid metabolism in human platelets by hydrodynamic stress. Biochem Biophys Acta 1988; 958: 108-15.
35. 4 release from activated neutrophils. Proc Natl Acad Sci USA 1983; 80: 4349-53.
36. 36. Berti F, Rossoni G, Magni F, et al. Nonsteroidal antiinflammatory drugs aggravate acute myocardial ischemia in the perfused rabbit heart: a role for prostacyclin. J Cardiovasc Pharmacol 1989; 12: 438-44.
37. 4 by human polymorphonuclear leukocytes. Br J Pharmacol 1989; 96: 186-92.
38. 38. Coccheri S, Biagi G. Defibrotide. Cardiovasc Drug Rev 1991; 9: 172-96.
39. 2. Federation Proc 1979; 38: 83-8.
40. 40. Moncada S, Korbut R, Bunting S, Vane JR. Prostacyclin is a circulating hormone. Nature 1978; 273: 767-8.
41. 41. Schrör K, Köhler P, Müller M, Peskar BA, Rösen P. Prostacyclin-thromboxane interactions in the platelet-perfused in vitro heart. Am J Physiol 1981; 241: H18-H25.
42. 42. Schrör K. Cytoprotection by prostacyclins in myocardial ischemia. In Zor U, Naor Z, Danon A, eds. New trends in lipid mediators research 1989, Vol. 3. Basel: Karger, pp. 246-251.
43. 43. Smith III EF, Kloster G, Stöcklin G, Schrör K. Effect of floprost (ZK 36 374) on membrane integrity in ischemic rabbit hearts. Biomed Biochim Acta 1984; 43: S155-8.
44. 44. Darius H, Osborne JA, Reibel DK, Lefer AM. Protective actions of a stable prostacyclin analog in ischemia induced membrane damage in rat myocardium. J Mol Cell Cardiol 1986; 19: 243-50.